|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: VIAGRA
Summary for Tradename: VIAGRA
|
|
Latest news for VIAGRAFemale Viagra that stimulates the body AND the mind could be on the market 'within three years'23 May 2013, 12:30 pm Viagra maker gives doctors the flick13 May 2013, 7:00 pm Viagra Available to Buy Online for Years8 May 2013, 6:08 am Viagra now available online7 May 2013, 11:48 pm Viagra to be sold to patients online6 May 2013, 4:40 pm Real Viagra to be sold directly to patients online in move against fakes6 May 2013, 3:13 pm Viagra Users Can Now Buy Pill Online6 May 2013, 1:22 pm Bashful? Viagra to Begin Selling Online6 May 2013, 9:03 am Bashful? Buy Viagra online6 May 2013, 7:55 am Courtesy of Yahoo News | ||||||||||||
Clinical Trials for: VIAGRAA Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions Status: Completed Condition: Pulmonary Arterial Hypertention Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery? Status: Recruiting Condition: Pulmonary Hypertension Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet. Status: Completed Condition: Erectile Dysfunction Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke Status: Terminated Condition: Ischemic Stroke Sildenafil for Prevention of Cerebral Vasospasm Status: Recruiting Condition: Subarachnoid Hemorrhage; Cerebral Vasospasm; Rupture of Intracranial Aneurysm Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil Status: Completed Condition: Healthy A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies Status: Not yet recruiting Condition: Erectile Dysfunction Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels Status: Completed Condition: Impotence Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles Status: Completed Condition: Endometrial Preparation; Frozen Embryo Transfer Sildenafil in Single Ventricle Patients Status: Recruiting Condition: Heart Disease Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer Ireland | VIAGRA | sildenafil citrate | TABLET; ORAL | 020895 | Mar 27, 1998 | RX | No | 5,250,534*PED | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pfizer Ireland | VIAGRA | sildenafil citrate | TABLET; ORAL | 020895 | Mar 27, 1998 | RX | No | 6,469,012*PED | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pfizer Ireland | VIAGRA | sildenafil citrate | TABLET; ORAL | 020895 | Mar 27, 1998 | RX | Yes | 5,250,534*PED | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pfizer Ireland | VIAGRA | sildenafil citrate | TABLET; ORAL | 020895 | Mar 27, 1998 | RX | Yes | 6,469,012*PED | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Paragraph IV activity for: VIAGRA
| Drugname | Dosage | Strength | RLD | Submissiondate |
| sildenafil citrate | Tablets | 25 mg and 50 mg | Viagra | 11/19/2004 |
| sildenafil citrate | Tablets | 100 mg | Viagra | 10/25/2004 |
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc